Team Archive - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes
Team Archive - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes
  • Our Company
    • Presentation
    • Presentation post-ASCO
    • Half-year results 2022
    • Management Team
    • Board of directors
    • Scientific Advisory Board
    • Contact
  • Products
    • Tedopi®
    • OSE-279
    • OSE-127
    • FR104
    • BI 765063
    • OSE-230
    • CLEC-1
    • BiCKI®
  • Research & Development
    • Scientific publications
  • Investors
    • Press Releases
    • Regulated information
    • Financial documents
    • General Shareholders’ meetings
  • Partnerships
    • Pharma partnerships
    • Clinical partnerships
    • Academic and public Partnerships
  • News
    • Agenda
    • Press Releases
  • Contact
en
  • fr

Projects Archives

June 2022

Jennifer Wargo, MD, M.M.Sc

June 2022

Charles N. Serhan, PhD, DSc

June 2022

Myriam Merad, MD, PhD

June 2022

Bernard Malissen, PhD

June 2022

Sophie Brouard, PhD

June 2022

Wolf-Hervé Fridman, MD

February 2022

Alexandre Lebeaut, MD

October 2021

Gérard Tobelem, MD

October 2021

Nicolas Poirier, PhD

October 2021

Didier Hoch, MD

  • 1
  • 2
  • Suivant

Head Office

22, boulevard Benoni Goulin
44200 Nantes – France

Tel : +33 (0)2 28 29 10 10

Email : contact@ose-immuno.com

Paris Office

10, place de Catalogne
75014 Paris – France

Tel : +33 (0)1 43 29 78 57

Fax : +33 (0)1 42 03 04 16

Our Company
Products
Investors
Agenda
Research & Development
Partnerships
Press Releases
Follow us
©2021 ose-immuno
Financial documents
Legal information and Personal data protection policy
Site made by Adveris